CIBC Private Wealth Group
DFTX

CIBC Private Wealth Group’s Definium Therapeutics DFTX Stock Holding History

CIBC Private Wealth Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.02K Hold
151
– – ﹤0.01% 2798
2025
Q3 		$1.78K Sell
151
-333
-69% -$3.11K ﹤0.01% 2742
2025
Q2 		$3.14K Buy
484
+61
+14% +$401 ﹤0.01% 2553
2025
Q1 		$2.07K Hold
423
– – ﹤0.01% 2685
2024
Q4 		$2.99K Hold
423
– – ﹤0.01% 2618
2024
Q3 		$2.41K Hold
423
– – ﹤0.01% 2771
2024
Q2 		$2.89K Sell
423
-11
-3% -$96 ﹤0.01% 2680
2024
Q1 		$4.13K Buy
+434
New +$2.48K ﹤0.01% 2558

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

CIBC Private Wealth Group's DFTX Position: Q4 2025 in Review

CIBC Private Wealth Group held its Definium Therapeutics (DFTX) position steady in Q4 2025 at 151 shares worth $2.02K. The position accounts for ﹤0.01% of the portfolio, ranked #2798.

CIBC Private Wealth Group first reported a position in DFTX in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.13K in Q1 2024. 208 funds tracked by Wall St. Rank hold DFTX as of Q4 2025.

  • CIBC Private Wealth Group held 151 shares of Definium Therapeutics worth $2.02K as of Q4 2025.
  • CIBC Private Wealth Group left its Definium Therapeutics share count unchanged in Q4 2025.
  • Definium Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2798 holding.
  • CIBC Private Wealth Group first reported a position in Definium Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Definium Therapeutics position peaked at $4.13K in Q1 2024.
  • 208 funds tracked by Wall St. Rank held Definium Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.